256 related articles for article (PubMed ID: 9876525)
21. Effect of direct compression excipients on the stability of ascorbic acid (vitamin c) tablets.
Ofoefule SI; Chukwube VO; Attama AA
Boll Chim Farm; 1999 Sep; 138(8):418-21. PubMed ID: 10622107
[TBL] [Abstract][Full Text] [Related]
22. A methodological evaluation and predictive in silico investigation into the multi-functionality of arginine in directly compressed tablets.
ElShaer A; Kaialy W; Akhtar N; Iyire A; Hussain T; Alany R; Mohammed AR
Eur J Pharm Biopharm; 2015 Oct; 96():272-81. PubMed ID: 26255158
[TBL] [Abstract][Full Text] [Related]
23. A novel multifunctional pharmaceutical excipient: modification of the permeability of starch by processing with magnesium silicate.
Rashid I; Al-Remawi M; Leharne SA; Chowdhry BZ; Badwan A
Int J Pharm; 2011 Jun; 411(1-2):18-26. PubMed ID: 21419206
[TBL] [Abstract][Full Text] [Related]
24. Eudragit E as excipient for production of granules and tablets from Phyllanthus niruri L spray-dried extract.
Pereira de Souza T; Martínez-Pacheco R; Gómez-Amoza JL; Petrovick PR
AAPS PharmSciTech; 2007 Apr; 8(2):Article 34. PubMed ID: 17622112
[TBL] [Abstract][Full Text] [Related]
25. Some factors affecting properties and dissolution behavior of tableted furosemide microspheres.
Akbuğa J
Pharmazie; 1992 Feb; 47(2):128-31. PubMed ID: 1635921
[TBL] [Abstract][Full Text] [Related]
26. Assessment of Albizia zygia gum as a binding agent in tablet formulations.
Odeku OA
Acta Pharm; 2005 Sep; 55(3):263-76. PubMed ID: 16375837
[TBL] [Abstract][Full Text] [Related]
27. Comparative study of different formulations of atenolol.
Yasmeen R; Shoaib MH; Khalid H
Pak J Pharm Sci; 2005 Jan; 18(1):47-51. PubMed ID: 16431383
[TBL] [Abstract][Full Text] [Related]
28. The preparation of orally disintegrating tablets using a hydrophilic waxy binder.
Abdelbary G; Prinderre P; Eouani C; Joachim J; Reynier JP; Piccerelle P
Int J Pharm; 2004 Jul; 278(2):423-33. PubMed ID: 15196646
[TBL] [Abstract][Full Text] [Related]
29. Effect of various disintegrants on the availability of directly compressed sulphadimidine tablets.
Aboutaleb AE; Attia AM; Habib FS
Pharmazie; 1983 Jul; 38(7):473-5. PubMed ID: 6634914
[TBL] [Abstract][Full Text] [Related]
30. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
[TBL] [Abstract][Full Text] [Related]
31. Preparation and characterization of a novel co-processed excipient of chitin and crystalline mannitol.
Daraghmeh N; Rashid I; Al Omari MM; Leharne SA; Chowdhry BZ; Badwan A
AAPS PharmSciTech; 2010 Dec; 11(4):1558-71. PubMed ID: 21052880
[TBL] [Abstract][Full Text] [Related]
32. Flow, packing and compaction properties of novel coprocessed multifunctional directly compressible excipients prepared from tapioca starch and mannitol.
Adeoye O; Alebiowu G
Pharm Dev Technol; 2014 Dec; 19(8):901-10. PubMed ID: 24089696
[TBL] [Abstract][Full Text] [Related]
33. Prediction of quality attributes (mechanical strength, disintegration behavior and drug release) of tablets on the basis of characteristics of granules prepared by high shear wet granulation.
Khan A
PLoS One; 2021; 16(12):e0261051. PubMed ID: 34882723
[TBL] [Abstract][Full Text] [Related]
34. Effect of excipients on tablet properties and dissolution behavior of theophylline-tableted microcapsules under different compression forces.
Lin SY
J Pharm Sci; 1988 Mar; 77(3):229-32. PubMed ID: 3373426
[TBL] [Abstract][Full Text] [Related]
35. Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations.
Korang-Yeboah M; Rahman Z; Shah D; Mohammad A; Wu S; Siddiqui A; Khan MA
Int J Pharm; 2016 Feb; 499(1-2):20-28. PubMed ID: 26688036
[TBL] [Abstract][Full Text] [Related]
36. Polyols as filler-binders for disintegrating tablets prepared by direct compaction.
Bolhuis GK; Rexwinkel EG; Zuurman K
Drug Dev Ind Pharm; 2009 Jun; 35(6):671-7. PubMed ID: 19274511
[TBL] [Abstract][Full Text] [Related]
37. Functionality of magnesium stearate derived from bovine and vegetable sources: dry granulated tablets.
Hamad ML; Gupta A; Shah RB; Lyon RC; Sayeed VA; Khan MA
J Pharm Sci; 2008 Dec; 97(12):5328-40. PubMed ID: 18351597
[TBL] [Abstract][Full Text] [Related]
38. Pharmaceutical granulation and tablet formulation using neural networks.
Kesavan JG; Peck GE
Pharm Dev Technol; 1996 Dec; 1(4):391-404. PubMed ID: 9552323
[TBL] [Abstract][Full Text] [Related]
39. Effect of drug substance particle size on the characteristics of granulation manufactured in a high-shear mixer.
Badawy SI; Lee TJ; Menning MM
AAPS PharmSciTech; 2000 Nov; 1(4):E33. PubMed ID: 14727898
[TBL] [Abstract][Full Text] [Related]
40. Application of fluidized hot-melt granulation (FHMG) for the preparation of granules for tableting; properties of granules and tablets prepared by FHMG.
Kidokoro M; Haramiishi Y; Sagasaki S; Shimizu T; Yamamoto Y
Drug Dev Ind Pharm; 2002 Jan; 28(1):67-76. PubMed ID: 11858526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
